Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia

Min Zhong; Julan Peng; Lanhua Xiang; Xinhuang Yang; Xianghua Wang; Yanbin Zhu

doi:10.12659/MSM.926924

15 October 2020 : Laboratory Research

Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia

Min Zhong^1ABCDEFG, Julan Peng^1ABCDEFG, Lanhua Xiang^1ABCDEFG, Xinhuang Yang^1ABCDEFG, Xianghua Wang^1ABCDEFG, Yanbin Zhu^2ABCDEFG*

DOI: 10.12659/MSM.926924

Med Sci Monit 2020; 26:e926924

Authors information Article notes Copyright and License information

View HTML version

Figure 3 EGCG dose-dependently promoted cell proliferation by downregulating HMGB1. (A) Cell proliferation assessed using CCK-8 assay. (B) Cell proliferation assessed using BrdU incorporation assay. * p<0.05, *** p<0.001.

Back to the Article

Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia

Your Privacy